NCT06789575View on ClinicalTrials.gov

Comparison of Bupivacaine Wound Infiltration Versus Wound Instillation to Minimize Postoperative Pain After Thyroid Surgery

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

May 1, 2027

Conditions
Thyroid Surgery
Interventions
DRUG

Bupivacaine

the patients will receive the content of a syringe (10 ml of bupivacaine 0.25%)

DRUG

Adrenaline

the patients will receive the content of a syringe 15 μg adrenaline

DRUG

Lidocaine (drug)

the patients will receive the content of a syringe 70 ml Lidocaine .

All Listed Sponsors
lead

Assiut University

OTHER